Looking for Clinical Notes & EndoAI for Doctors? Visit Notes in Endocrinology →

How does ezetimibe work?

Medically reviewed by Dr. Om J Lakhani on 18 Oct 2026 · Updated 18 Oct 2026

Short answer

Ezetimibe lowers LDL (bad) cholesterol by blocking a protein in the small intestine that absorbs cholesterol from food and bile. It works differently from statins, so doctors often combine the two when a statin alone is not enough or is not tolerated.

Ezetimibe is a cholesterol-lowering medicine that has been used for more than twenty years. It is often prescribed in India, either on its own or as a combined tablet with a statin. If your doctor has suggested it, here is how it works and where it fits.

Where does the cholesterol in your blood come from?

Your blood cholesterol has two main sources:

  • Your liver makes it. This is actually the larger share for most people.
  • Your gut absorbs it. Some comes from food such as ghee, butter, egg yolk and meat. A large amount also comes from bile, the digestive juice your liver pours into the gut, which is rich in cholesterol. Much of that cholesterol is normally absorbed back into the body.

Most cholesterol medicines target one of these two sources. Statins work mainly on the liver. Ezetimibe works on the gut.

How does ezetimibe block cholesterol?

The lining of your small intestine has a protein called NPC1L1. Think of it as a doorway that lets cholesterol from food and bile into the body.

Ezetimibe sits on this doorway and partly closes it. As a result:

  1. Less cholesterol is absorbed from the gut.
  2. Less cholesterol reaches the liver.
  3. The liver, now short of cholesterol, pulls more LDL cholesterol out of the blood to make up the gap.
  4. Your blood level of LDL (“bad”) cholesterol falls.

On its own, ezetimibe lowers LDL modestly. Its real strength is in combination. When added to a statin, it gives a further, worthwhile fall in LDL, because the two medicines attack cholesterol from different directions.

Does lowering LDL with ezetimibe actually protect the heart?

Yes, this has been tested. In a large trial called IMPROVE-IT, people who had recently had a heart attack or similar event were given a statin with either ezetimibe or a dummy tablet. Those who also received ezetimibe had lower LDL and fewer heart attacks and strokes over about seven years. The benefit was modest but real, and it supported the idea that “lower LDL is better” for people at high risk.

Current European and Indian guidelines recommend adding ezetimibe when a statin alone does not bring LDL down to your target. The Lipid Association of India sets fairly strict targets for many Indians, because heart disease in India tends to strike earlier and harder than in many Western countries. To understand why LDL matters so much, read the story of a plaque, from cholesterol to a heart attack.

Who is usually offered ezetimibe?

Your doctor may discuss ezetimibe if:

  • Your LDL is still above target even though you are on a statin.
  • You cannot tolerate a statin, or can only tolerate a low strength.
  • You have a very high LDL from birth, such as familial hypercholesterolaemia, and need several medicines.
  • You have diabetes, kidney disease or previous heart disease, where targets are stricter.

It is meant to be used alongside a heart-healthy diet and regular activity, not instead of them.

How quickly does it work, and how will you know?

Ezetimibe starts to lower cholesterol within about two weeks. You will not feel any different, because high cholesterol itself has no symptoms. The only way to know it is working is a repeat lipid profile blood test, usually a few weeks to a few months after starting, as your doctor advises.

When you read your report, look at the LDL line. Indian labs print it in mg/dL. Your doctor will tell you what your personal target is, which depends on your overall heart risk.

Is ezetimibe safe?

For most people ezetimibe is well tolerated. Possible side effects include:

  • Mild stomach upset, loose stools or tiredness.
  • Muscle aches, especially when combined with a statin, although true muscle damage is rare.
  • Small changes in liver blood tests, again mostly when combined with a statin.

Tell your doctor if you have liver disease, are pregnant or planning a pregnancy, or are breastfeeding, as the plan may change. If you develop unexplained muscle pain or dark urine, contact your doctor promptly.

Do not stop or change any cholesterol medicine on your own because your report looks good. The good number is usually because of the medicine.

How is it different from statins?

StatinsEzetimibe
Main site of actionLiverSmall intestine
How it lowers LDLReduces cholesterol makingReduces cholesterol absorption
Size of LDL fallLargeModest alone, useful added on
Heart benefit provenYes, in many trialsYes, when added to a statin

Neither one is “better” in every case. Statins remain the first choice for most people because of their large proven benefit. Ezetimibe is the most common partner.

What should you ask your doctor?

  • What is my LDL target, and how far am I from it?
  • Do I need ezetimibe on top of my statin, or instead of it?
  • When should I repeat my lipid profile?
  • Are there other options, such as newer injectable medicines, if I still do not reach target?

High cholesterol often travels with diabetes, fatty liver and extra waist fat. If you have these too, it may help to see an endocrinologist. Read who an endocrinologist is, check your waist-to-height ratio, or book a consultation.

When to see an endocrinologist

  • You have chest pain, breathlessness or pressure in the chest, especially on exertion: call 108 or 112, or go to the nearest emergency department immediately
  • You have unexplained muscle pain or weakness, or dark urine, while on cholesterol medicines
  • Your LDL cholesterol is very high, or a close relative had a heart attack at a young age
  • You develop yellowing of the eyes or skin

Chest pain, fainting, severe breathlessness or confusion: call 108 or 112, or go to the nearest emergency department.

Book In-Person / Online Consultation

References

  1. Cannon CP et al. Ezetimibe added to statin therapy after acute coronary syndromes (IMPROVE-IT). N Engl J Med 2015 (PMID 26444734)
  2. Puri R et al. Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients. J Clin Lipidol 2024 (PMID 38485619)
  3. Mach F et al. 2025 focused update of the 2019 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J 2025 (PMID 40878289)
  4. MedlinePlus: Ezetimibe

This page is general health information and does not replace a consultation with your own doctor. Please read our medical disclaimer.

Book In-Person / Online Consultation